TBPH Operating Cash Flow Growth
Theravance Biopharma Inc · Operating Cash Flow Growth
TBPH Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-78.85%period ending
TBPH TTM Cash from Operations YoY % (-63.78% → -78.85%)
Year-over-year change
High-resolution chart · PNG
TBPH operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -78.8478% | |
| 726.3574% | |
| 2,167.9757% | |
| 2,221.5548% | |
| 2,891.5575% | |
| 293.6302% | |
| 57.273% | |
| 92.3521% | |
| 94.8325% | |
| 90.2418% | |
| 85.5624% | |
| -42.5434% | |
| -31.9943% | |
| -4.9256% | |
| 10.0391% | |
| 54.2564% | |
| 50.8735% | |
| 38.1288% | |
| 16.9906% | |
| 7.7977% | |
| -20.4732% | |
| -25.0169% | |
| -5.1243% | |
| -10.533% | |
| 5.6242% | |
| 13.0307% | |
| -111.0422% | |
| -115.4837% | |
| -94.8838% | |
| -140.9907% | |
| 43.8618% | |
| 43.2908% | |
| 12.497% | |
| 17.5256% | |
| -103.1054% | |
| -76.7917% | |
| -8.7966% | |
| 11.5007% | |
| 41.377% | |
| 41.1078% | |
| 31.7896% | |
| 25.803% | |
| 3.5957% | |
| -5.8676% | |
| -10.758% | |
| -36.1361% | |
| -44.8053% | |
| -54.6894% | |
| -63.7757% |